Clinical Trial Update: Effect of Evolocumab on Coronary Endothelial Function [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating evolocumab's effect on coronary endothelial function in adults with HIV and coronary artery disease has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Human Immunodeficiency Virus, Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-07-24